Breast Cancer Research and Treatment

, Volume 88, Issue 3, pp 257–261 | Cite as

Bone mineral density and adjuvant therapy in breast cancer survivors

  • C. Crandall
  • L. Petersen
  • P. A. Ganz
  • G. A. Greendale
Report

Abstract

Compared to mean values from a US database, premenopausal breast cancer survivors (BCS) had significantly higher whole body bone mineral density (BMD) compared to age and ethnicity matched referents; higher whole body BMD was present in all premenopausal BCS, including those who received chemotherapy, tamoxifen+chemotherapy, or no adjuvant therapy. Postmenopausal BCS who had received no adjuvant therapy also had higher whole body BMD compared to similarly aged women. In contrast, hip and lumbar spine BMD values in BCS were similar to those of the population-based database.

Keywords

adjuvant therapy bone density breast cancer menopause osteoporosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Breast Cancer Facts and Figures 2003–2004. American Cancer Society, Atlanta, Georgia, 2003.Google Scholar
  2. Key, TJ, Pike, MC 1988The role of oestrogens and progestagens in the epidemiology and prevention of breast cancerEur J Cancer Clin Oncol242943Google Scholar
  3. Cauley, JA, Lucas, FL, Kuller, LH, Vogt, MT, Browner, WS, Cummings, SR 1996Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research GroupJAMA27614041408Google Scholar
  4. Nelson, RL, Turyk, M, Kim, J, Persky, V 2002Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort.BMC Cancer222Google Scholar
  5. Nelson DA, Darga LL, Simon MS, Severson RK: Radial bone density and breast cancer risk in white and African--American women. Osteoporos Int, 2004 Google Scholar
  6. Zmuda, JM, Cauley, JA, Ljung, BM, Bauer, DC, Cummings, SR, Kuller, LH 2001Bone mass and breast cancer risk in older women: differences by stage at diagnosisJ Natl Cancer Inst93930936Google Scholar
  7. Zhang, Y, Kiel, DP, Kreger, BE, Cupples, LA, Ellison, RC, Dorgan, JF, Schatzkin, A, Levy, D, Felson, DT 1997Bone mass and the risk of breast cancer among postmenopausal womenN Engl J Med336611617Google Scholar
  8. Buist, DS, LaCroix, AZ, Barlow, WE, White, E, Cauley, JA, Bauer, DC, Weiss, NS 2001Bone mineral density and endogenous hormones and risk of breast cancer in postmenopausal women (United States)Cancer Causes Control12213222Google Scholar
  9. Klift, M, Laet, CE, Coebergh, JW, Hofman, A, Pols, HA 2003Bone mineral density and the risk of breast cancer: the Rotterdam StudyBone32211216Google Scholar
  10. Nguyen, TV, Center, JR, Eisman, JA 2000Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology StudyMaturitas362734Google Scholar
  11. Looker, AC, Orwoll, ES, Johnston, CC,Jr, Lindsey, RL, Wahner, HW, Dunn, WL, Calvo, MS, Harris, TB, Heyse, SP 1997Prevalence of low femoral bone density in older US adults from NHANES IIIJ Bone Miner Res1217611768Google Scholar
  12. Pakilit, AT, Kahn, BA, Petersen, L, Abraham, LS, Greendale, GA, Ganz, PA 2001Making effective use of tumor registries for cancer survivorship researchCancer,9213051314Google Scholar
  13. Ganz, PA, Greendale, GA, Petersen, L, Kahn, B, Bower, JE 2003Breast cancer in younger women: reproductive and late health effects of treatmentJ Clin Oncol2141844193Google Scholar
  14. SAS Institute Inc. SAS/STAT Users Guide, Version 8.02. Cary, NC: SAS Institute Inc., 1989 Google Scholar
  15. Vehmanen, L, Saarto, T, Elomaa, I, Makela, P, Valimaki, M, Blomqvist, C 2001Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatmentEur J Cancer3723732378Google Scholar
  16. Shapiro, CL, Manola, J, Leboff, M 2001Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancerJ Clin Oncol1933063311Google Scholar
  17. Saarto, T, Blomqvist, C, Risteli, J, Risteli, L, Sarna, S, Elomaa, I 1998Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patientsBr J Cancer78240245Google Scholar
  18. Headley, JA, Theriault, RL, LeBlanc, AD, Vassilopoulou-Sellin, R, Hortobagyi, GN 1998Pilot study of bone mineral density in breast cancer patients treated with adjuvant chemotherapyCancer Invest16611Google Scholar
  19. Saarto, T, Blomqvist, C, Valimaki, M, Makela, P, Sarna, S, Elomaa, I 1997Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patientsJ Clin Oncol1513411347Google Scholar
  20. Bruning, PF, Pit, MJ, Jong-Bakker, M, Ende, A, Hart, A, Enk, A 1990Bone mineral density after adjuvant chemotherapy for premenopausal breast cancerBr J Cancer61308310Google Scholar
  21. Yoneda, K, Tanji, Y, Ikeda, N, Miyoshi, Y, Taguchi, T, Tamaki, Y, Noguchi, S 2002Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in JapanCancer Lett186223230Google Scholar
  22. Marttunen, MB, Hietanen, P, Titinen, A, Roth, HJ, Viinikka, L, Ylikorkala, O 1999Effects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancerCalcif Tissue Int65365368Google Scholar
  23. Saarto, T, Blomqvist, C, Valimaki, M, Makela, P, Sarna, S, Elomaa, I 1997Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogensBr J Cancer75602605Google Scholar
  24. Barni, S, Lissoni, P, Tancini, G, Ardizzoia, A, Cazzaniga, M 1996Effects of one-year adjuvant treatment with tamoxifen on bone mineral density in postmenopausal breast cancer womenTumori826567Google Scholar
  25. Powles, TJ, Hickish, T, Kanis, JA, Tidy, A, Ashley, S 1996Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal womenJ Clin Oncol147884Google Scholar
  26. Love, RR, Barden, HS, Mazess, RB, Epstein, S, Chappell, RJ 1994Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 yearsArch Intern Med15425852588Google Scholar
  27. Kristensen, B, Ejlertsen, B, Dalgaard, P, Larsen, L, Holmegaard, SN, Transbol, I, Mouridsen, HT 1994Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized studyJ Clin Oncol12992997Google Scholar
  28. Fornander, T, Rutqvist, LE, Sjoberg, HE, Blomqvist, L, Mattsson, A, Glas, U 1990Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal womenJ Clin Oncol810191024Google Scholar
  29. Fornander, T, Rutqvist, LE, Wilking, N, Carlstrom, K, Schoultz, B 1993Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancerEur J Cancer29A497500Google Scholar
  30. Neal, AJ, Evans, K, Hoskin, PJ 1993Does long-term administration of tamoxifen affect bone mineral density?Eur J Cancer 29A19711973Google Scholar
  31. Love, RR, Mazess, RB, Barden, HS, Epstein, S, Newcomb, PA, Jordan, VC, Carbone, PP, DeMets, DL 1992Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancerN Engl J Med326852856Google Scholar
  32. Fentiman, IS, Saad, Z, Caleffi, M, Chaudary, MA, Fogelman, I 1992Tamoxifen protects against steroid-induced bone lossEur J Cancer28684685Google Scholar
  33. Cuzick, J, Allen, D, Baum, M, Barrett, J, Clark, G, Kakkar, V, Melissari, E, Moniz, C, Moore, J, Parsons, V,  et al. 1992Long term effects of tamoxifen. Biological effects of Tamoxifen Working PartyEur J Cancer29A1521Google Scholar
  34. Ryan, WG, Wolter, J, Bagdade, JD 1991Apparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: preliminary studyOsteoporos Int23941Google Scholar
  35. Kalef-Ezra, JA, Pavlidis, N, Klouvas, G, Karantanas, A, Hatzikonstantinou, I, Glaros, D 1996Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifenBreast Cancer Res Treat37161168Google Scholar
  36. Greep, NC, Giuliano, AE, Hansen, NM, Taketani, T, Wang, HJ, Singer, FR 2003The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancerAm J Med114653659Google Scholar
  37. Beckmann, MW, Jap, D, Djahansouzi, S, Nestle-Kramling, C, Kuschel, B, Dall, P, Brumm, C, Bender, HG 2001Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence ratesOncology60199206Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • C. Crandall
    • 1
  • L. Petersen
    • 2
  • P. A. Ganz
    • 2
    • 3
  • G. A. Greendale
    • 4
  1. 1.Carolyn Crandall, David Geffen School of Medicine at University of California, Los AngelesIris Cantor-UCLA Women’s Health CenterLos AngelesUSA
  2. 2.Division of Cancer Prevention and Control ResearchJonsson Comprehensive Cancer Center at UCLALos Angeles
  3. 3.UCLA Schools of Medicine and Public HealthLos Angeles
  4. 4.Division of Geriatrics, Deptartment of Internal MedicineDavid Geffen School of Medicine at University of CaliforniaLos Angeles

Personalised recommendations